ALPHA

Head to head

Finasteride vs Minoxidil

Two different mechanisms, both FDA-approved for male pattern hair loss, and the question most men are actually asking is whether to run both. Neither label answers that one.

Reviewed

The short answer

Neither one is the answer to the other, and that is the genuinely useful finding here. Both are FDA-approved for androgenetic alopecia in men — finasteride as PROPECIA 1 mg under NDA 020788, topical minoxidil as ROGAINE Extra Strength 5% under NDA 020834 — and they act on entirely different things. Finasteride reduces the hormone that drives the miniaturisation; what minoxidil does is not stated anywhere on its label, which is a Drug Facts panel and gives only a Purpose, "Hair regrowth treatment for men".

The difference nobody reports is how far each label's evidence runs. PROPECIA's clinical studies section publishes hair counts out to 5 years, including a 277-hair difference from placebo at year five and the fact that 100% of placebo men had lost hair by then against 35% on the drug. The ROGAINE Drug Facts stops dead at 48 weeks: "hair regrowth has not been shown to last longer than 48 weeks in large clinical trials". That is not a statement that minoxidil stops working. It is a statement that the label declines to claim anything past that point, and every page that draws a minoxidil results curve at month eighteen is inventing the interesting part.

They are commonly taken together and NEITHER LABEL MENTIONS THE OTHER DRUG. Combination use is practice, not labelling. The best evidence for it that this page found is a randomised 12-month study in 450 Chinese men that ran finasteride 1 mg, 5% minoxidil and both: improvement in 80.5%, 59% and 94.1% respectively. One population, one protocol, open-label, investigator-rated, no placebo arm — worth reading, not worth treating as a labelled claim.

The safety content that actually separates them is about who else is in the house. Finasteride is contraindicated in pregnancy and its label makes the tablet coating itself the barrier: the coating "will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed." A crushed or split tablet is outside what the label describes. Minoxidil's Drug Facts says only "May be harmful if used when pregnant or breast-feeding", which is a warning about using it, not about handling it.

3 of 13 dimensions are materially the same. They are marked below rather than dressed up as differences.

Finasteride

Propecia (1 mg) · generic finasteride 1 mg

A type II 5α-reductase inhibitor, taken as a 1 mg tablet once daily. Prescription only, men only, and the only oral drug FDA-approved for male pattern hair loss.

Dosing protocol →

Topical minoxidil

Rogaine · Rogaine Extra Strength · generic minoxidil solution and foam

A 5% solution or foam applied to the scalp twice a day. Sold over the counter under a Drug Facts label, with no prescription and no prescriber involved.

Dosing protocol →

Side by side

Every row carries how well supported it is. A claim that only reflects common practice is labelled as such rather than presented as fact.

DimensionFinasterideTopical minoxidilBasis
How you get itPrescription onlyOver the counter, no prescriberlabelTwo different document types, not two shades of the same thing. PROPECIA files a HUMAN PRESCRIPTION DRUG LABEL with numbered sections 1 to 17; ROGAINE files a HUMAN OTC DRUG LABEL — a Drug Facts panel with a Use, a Warnings list and Directions, and no clinical studies section at all.
US applicationNDA 020788 (Propecia 1 mg)NDA 020834 (Rogaine Extra Strength 5% solution)labelBoth are full NDAs approved for hair, which is why this comparison is between two approved drugs rather than an approved one and an off-label one. The 5% foams are approved generics of the solution rather than separate NDAs.
Who the label is forsameMen onlyMen onlylabelPROPECIA: "in MEN ONLY", and its section 14 records a 137-woman study in which "effectiveness could not be demonstrated". The ROGAINE men's label opens its Do not use list with "you are a woman" and its display panel reads "Not For Use By Women". A women's minoxidil product exists; this one is not it.
Where on the scalpVertex and anterior mid-scalp; bitemporal recession not establishedVertex only; explicitly not for a receding hairlinelabelPROPECIA: "Efficacy in bitemporal recession has not been established", and its section 14 notes the mid-scalp hair counts "did not include the area of bitemporal recession or the anterior hairline". ROGAINE is narrower still — Use: "to regrow hair on the top of the scalp (vertex only)", and Do not use if "your hair loss is on the front of the scalp."
Labelled dose1 mg once daily, with or without meals1 mL with the dropper, 2 times a day, to the scalplabelVerbatim: "The recommended dose of PROPECIA is one tablet (1 mg) taken once daily" and "apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area". The minoxidil label adds its own answer to the obvious follow-up: "using more or more often will not improve results."
When the label says to judge itThree months or more2 months for some, at least 4 for otherslabelPROPECIA: "In general, daily use for three months or more is necessary before benefit is observed." ROGAINE: "Results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results", and its Stop use list includes "you do not see hair regrowth in 4 months."
How far the label's evidence runs5 years — hair counts published at 1, 2 and 5 years48 weeks, and it says solabelThe single largest asymmetry here. PROPECIA reports a 277-hair difference from placebo at 5 years and that "100% of men in the placebo group demonstrated hair loss, compared with 35% of men treated with PROPECIA". ROGAINE states only that "hair regrowth has not been shown to last longer than 48 weeks in large clinical trials". Past its own horizon a label says nothing, and nothing is what is printed here.
What happens if you stopsameReversal within 12 monthsHair loss begins againlabelBoth are maintenance, and both labels say so without hedging. PROPECIA: "Withdrawal of treatment leads to reversal of effect within 12 months." ROGAINE: "continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again." Neither is a course of treatment with an end.
Pregnancy and handlingContraindicated; the intact coating is the stated barrier"May be harmful if used when pregnant or breast-feeding"labelNot the same kind of warning. Finasteride's is about a household member touching the drug: tablets "are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed", and if contact happens "the contact area should be washed immediately with soap and water." Break the coating and the protection is gone. Minoxidil's line addresses the user, not a bystander.
Systemic effects the label warns aboutPSA suppression; the high-grade prostate cancer signalChest pain, rapid heartbeat, faintness, swelling, weight gainlabelBoth lists are real and neither is the other's. Finasteride lowers PSA, so tell whoever orders the test. Minoxidil is a vasodilator whose oral form is an antihypertensive, which is why an over-the-counter hair product carries "Ask a doctor before use if you have heart disease" and a Stop use list headed by "chest pain, rapid heartbeat, faintness, or dizziness occurs".
Using both togethersameNot described on the labelNot described on the labelpracticeThe reason most people land on this page, and neither FDA label mentions the other drug even once. Combining them is ordinary clinical practice and it is unlabelled practice: no approved product pairs them, no label states a sequence, and nothing establishes whether the four-month and three-month judgement points still apply when both are started at once.
Head-to-head and combination result80.5% improved at 12 months59% improved at 12 monthsliteratureBoth arms of one randomised study of 450 Chinese men with male androgenetic alopecia, 428 evaluated at 12 months; the third arm, both drugs together, reached 94.1%. Its own conclusion: "finasteride is superior to 5% minoxidil, while the combined medication showed the best efficacy." Read the design with the number — open randomisation, investigator-rated improvement, no placebo arm, one national population.
Cost and supplyGeneric 1 mg tablets, one a day, filled as a prescriptionA 60 mL bottle the carton calls "One Month Supply"labelTwo different spending patterns rather than two prices. The minoxidil carton supplies its own arithmetic — 60 mL at 2 mL a day is thirty days — while finasteride is dispensed in whatever quantity the prescription says. No dollar figure is stated here; the finasteride cost tool linked below uses CMS acquisition data and says what that is and is not, and the bottle-duration tool does the minoxidil division.
label
Stated on the FDA label
guideline
Clinical practice guideline
literature
Published literature
practice
Common practice, not documented

Which one

Choose Finasteride if

  • Your hair loss includes the mid-scalp or you want the drug with five years of published label data behind it rather than 48 weeks.
  • You would rather take one tablet a day than apply a solution twice a day for the rest of your life. Adherence is the quiet reason topical treatment fails.
  • You want the option that acts on the hormonal driver rather than on the follicle, and you have talked through the sexual-function and PSA content on the label with a prescriber.
  • Nobody in your household is or may become pregnant, or you are content that the tablets stay intact and out of reach — which is exactly the condition the label attaches to its own safety claim.

Choose Topical minoxidil if

  • You want to start today without a prescriber, and you accept an over-the-counter Drug Facts panel in place of a full prescribing information.
  • A systemic 5α-reductase inhibitor is not something you want, for any reason, including reasons a label cannot adjudicate.
  • Your loss is at the vertex, which is the only place the men's 5% label claims regrowth.
  • You are already on finasteride and want to add the other approved mechanism. That is the ordinary reason for minoxidil to be the second drug rather than the first.

Framing this as a choice is usually the mistake. Both are approved for the same condition in the same men, they work on different things, and the trial that ran all three arms put the combination ahead of either alone. What no label will tell you is how to combine them, when to judge the pair, or whether the sequence matters — that is unlabelled practice, and this page says so rather than filling the gap. The other thing neither drug does is regrow hair at the temples: one label says efficacy there "has not been established" and the other says it is "not intended for frontal baldness or receding hairline".

Frequently asked questions

Can I use finasteride and minoxidil at the same time?
People routinely do, and it is unlabelled. Neither FDA label mentions the other drug: PROPECIA's prescribing information describes a 1 mg tablet once daily and says nothing about a topical, and the ROGAINE Drug Facts describes 1 mL twice a day and says nothing about an oral. The best evidence this page found for the pair is a randomised 12-month study in 450 Chinese men with male androgenetic alopecia in which 80.5% improved on finasteride 1 mg, 59% on 5% minoxidil and 94.1% on both, concluding that "the combined medication showed the best efficacy." That is one open-label, investigator-rated, placebo-free trial in one population — a reason to discuss the combination with a prescriber, not a labelled instruction.
Which one works better?
On the one trial that randomised both, finasteride — 80.5% improved against 59% at 12 months, in 450 Chinese men. What cannot be done is to compare the two FDA labels directly, and most pages that answer this question do exactly that. PROPECIA publishes hair counts in a 1-inch circle against placebo in men aged 18 to 41; the ROGAINE Drug Facts publishes no hair count at all, only that "5% minoxidil topical solution for men provided more hair regrowth than 2% minoxidil topical solution" in "mostly white men aged 18-49 years with moderate degrees of hair loss". Those are different endpoints in different populations and subtracting them measures nothing.
How long until I know whether it is working?
Three months at the earliest for finasteride and four months for minoxidil, both from the labels. PROPECIA: "In general, daily use for three months or more is necessary before benefit is observed." ROGAINE: "Results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results", with "you do not see hair regrowth in 4 months" on its Stop use and ask a doctor list. Judging either one earlier is judging it before its own label says it can be judged, and neither label says what to do if you started both on the same day.
What happens if I stop?
Both labels answer, and both answers are the same answer. PROPECIA: "Withdrawal of treatment leads to reversal of effect within 12 months." ROGAINE: "continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again." These are maintenance treatments and the benefit is conditional on continuing, which is the single most important thing to understand before starting either. The finasteride label also puts a number on the underlying trajectory: at five years, 100% of men in the placebo group had lost hair against 35% on the drug.
Does minoxidil stop working after a year?
The label does not say that, and it does not say the opposite either. What it says is "hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with 5% minoxidil topical solution for men." That is a statement about the length of the trials, not about the drug losing effect. It is also the exact point past which any month-by-month minoxidil results chart you see online is extrapolating, because the approved label makes no claim beyond it. Finasteride is the opposite case: its label carries hair counts out to five years.
Is either one safe for my partner to be around?
This is the one place the two labels are genuinely far apart. Finasteride is contraindicated in pregnancy and the protection its label names is physical: tablets "are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed", and "if a pregnant woman comes in contact with crushed or broken PROPECIA tablets, the contact area should be washed immediately with soap and water." So the intact tablet is the safeguard, and crushing or breaking one removes it. The minoxidil Drug Facts carries a single line — "May be harmful if used when pregnant or breast-feeding" — which addresses someone using the product, not someone sharing a bathroom with it.
Will either of them fix a receding hairline?
Neither label claims to. PROPECIA states that "efficacy in bitemporal recession has not been established", and its anterior mid-scalp study explicitly excluded "the area of bitemporal recession or the anterior hairline" from the hair counts. The men's 5% minoxidil label goes further and rules it out in the Do not use list: "your hair loss is on the front of the scalp. 5% minoxidil topical solution is not intended for frontal baldness or receding hairline." Plenty of men use both there anyway. That is use the labels do not cover, and no efficacy statement on either label applies to it.

Sources

  1. [1]FDA label — PROPECIA (finasteride) tablets, 1 mg, Organon LLC (DailyMed SPL 6f904709-65aa-44ce-b144-b4c8a0416e36; approval block NDA 020788, marketing category NDA; document type HUMAN PRESCRIPTION DRUG LABEL). Source of "indicated for the treatment of male pattern hair loss (androgenetic alopecia) in MEN ONLY. Efficacy in bitemporal recession has not been established.", "The recommended dose of PROPECIA is one tablet (1 mg) taken once daily.", "In general, daily use for three months or more is necessary before benefit is observed. Continued use is recommended to sustain benefit, which should be re-evaluated periodically. Withdrawal of treatment leads to reversal of effect within 12 months.", the coating statement "PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets have not been broken or crushed.", and the section 14 five-year figures — "resulting in a 277-hair difference (p<0.001, PROPECIA [n=219] vs placebo [n=15]) at 5 years" and "At 5 years, 100% of men in the placebo group demonstrated hair loss, compared with 35% of men treated with PROPECIA."
  2. [2]FDA label — MEN'S ROGAINE EXTRA STRENGTH UNSCENTED (minoxidil) 5% topical solution, Kenvue Brands LLC (DailyMed SPL ccaecec5-5348-4b24-9190-5464c50f6d80; approval block NDA 020834, marketing category NDA; document type HUMAN OTC DRUG LABEL). Source of the Use "to regrow hair on the top of the scalp (vertex only, see pictures on side of carton)", the Direction "apply one mL with dropper 2 times a day directly onto the scalp in the hair loss area", "using more or more often will not improve results", "continued use is necessary to increase and keep your hair regrowth, or hair loss will begin again", "Results may occur at 2 months with twice a day usage. For some men, you may need to use this product for at least 4 months before you see results.", "hair regrowth has not been shown to last longer than 48 weeks in large clinical trials with continuous treatment with 5% minoxidil topical solution for men", "May be harmful if used when pregnant or breast-feeding.", "Ask a doctor before use if you have heart disease" and the Do not use line "your hair loss is on the front of the scalp. 5% minoxidil topical solution is not intended for frontal baldness or receding hairline."
  3. [3]Hu R, Xu F, Sheng Y, Qi S, Han Y, Miao Y. Combined treatment with oral finasteride and topical minoxidil in male androgenetic alopecia: a randomized and comparative study in Chinese patients. Dermatol Ther. 2015;28(5):303–308 (PMID 26031764). "450 Chinese MAGA patients were randomly assigned to receive finasteride (n = 160), minoxidil (n = 130) and combined medication (n = 160) for 12 months." "At 12 months, 80.5, 59, and 94.1% men treated with finasteride, 5% minoxidil and the combination therapy showed improvement, respectively." "In conclusion, finasteride is superior to 5% minoxidil, while the combined medication showed the best efficacy."
  4. [4]Khandpur S, Suman M, Reddy BS. Comparative efficacy of various treatment regimens for androgenetic alopecia in men. J Dermatol. 2002;29(8):489–498 (PMID 12227482). The earlier open randomised parallel-group study of the same combination — "One hundered male patients with AGA of Hamilton grades II to IV were enrolled in an open, randomized, parallel-group study" of "oral finasteride (1 mg per day), topical 2% minoxidil solution and topical 2% ketoconazole shampoo alone and in combination", reporting that "At the end of one year, hair growth was observed in all the groups with best results recorded with a combination of finasteride and minoxidil". Note the minoxidil arm was 2%, not the 5% product this page compares
  5. [5]Drugs@FDA: FDA-Approved Drugs — used to confirm NDA 020788 (PROPECIA, male pattern hair loss) and NDA 020834 (ROGAINE Extra Strength 5% topical solution, over the counter) as two separate full approvals for the same condition

Next steps

Other comparisons

Educational reference, not medical advice. Which medication suits you is a decision for your prescriber.